MUHC Lymphedema Program

For the hundreds of courageous people in our community who have survived or are still battling the ravages of breast, melanoma, uterine, prostate, or ovarian cancer, lymphedema is a horrible consolation prize. The McGill University Health Centre’s (MUHC) Lymphedema Program provides comprehensive information, as well as specialized support and rehabilitation services for those suffering from this debilitating condition.

Dr. Anna Towers

Director of the MUHC’s Lymphedema Program, MUHC

The Challenge

Lymphedema is a condition brought on by a compromised lymphatic system, common in patients who have undergone surgery, the removal of lymph nodes, or radiation therapy for the treatment of various cancers. It causes severe fluid retention and tissue swelling in any part of the body: the arms and shoulders, legs, trunk or abdomen, and there is no cure or drug treatment for this chronic and progressive condition. For more than 80,000 Quebecers, this condition is a painful and debilitating daily reality and the psycho-social effects of this disfiguring condition, including depression and anxiety, often have a profound impact on those afflicted.

The Solution

The MUHC’s Lymphedema program is the only specialized medical service for lymphedema care in Quebec, and it is internationally recognized for its clinical, educational and research leadership. The program offers consultation, prevention, rehabilitation as well as education services, which are critical in facilitating the self-management of the condition.

The MUHC is truly setting the standard of care for cancer patients with lymphedema in Canada and around the world. To ensure that it remains at the forefront of helping patients with this debilitating condition, it must:

  • Increase the number of patients being seen at the MUHC’s two lymphedema clinics
  • Decrease wait times for one-on-one consultations – currently the program has a five to six month waiting list
  • Increase the number of clinical trials available to lymphedema patients with extremely complex and severe cases
  • Provide more educational workshops to nurses, physiotherapists and lymphedema therapists across Quebec and North America – increasing the number of specialists able to treat the condition

How you can help

We are raising $300,000 to help support the MUHC’s Lymphedema Program.

For more information, please contact Miguel Burnier, directeur du  développement, miguel.burnierjr@muhc.mcgill.ca, ou au 514 934-1934, poste 71205.

You can donate online, download our donation form or call us at 514-843-1543.

Follow Us

LEAP has selected Centre universitaire de santé McGill - McGill University Health Centre cardiologist & Research Institute of the McGill University Health Centre researcher, Dr. Abhinav Sharma’s, MyHeart Counts Canada mobile application for their Healthy Future Accelerator. MyHeart Counts Canada’s goal is to get Canadians moving for improved cardiovascular health. Dr. Sharma’s app uses artificial-intelligence with real-time feedback and support to improve physical activity incrementally. LEAP is donating $100, 000 to support the continued development of Dr. Sharma’s app through the MUHC Foundation’s Fix Broken Hearts campaign. Watch: 📺 youtu.be/GG2HKWxVfxA

LEAP a choisi l'application mobile MyHeart Counts Canada du Dr Abhinav Sharma, cardiologue du CUSM et chercheur de l'IR-CUSM, pour leur accélérateur Horizons Santé. L’objectif de MyHeart Counts Canada est de faire bouger les Canadiens pour une meilleure santé cardiovasculaire. L'application mobile du Dr Sharma utilise l'intelligence artificielle avec rétroaction et l’assistance en temps réel pour améliorer progressivement l'activité physique. LEAP fait un don de 100 000 $ pour soutenir le développement continu de l'application du Dr Sharma dans le cadre de la campagne Souder les cœurs brisés de la Fondation du CUSM.
... See MoreSee Less

View on Facebook

Ce « Mardi je donne » est presque terminé! ⏰ Pour chaque femme dont la vie a été anéantie par le cancer de l’ovaire ou de l’endomètre. Pour chaque mère qui ne verra pas ses enfants grandir en raison de ces maladies. Pour chaque femme qui lutte actuellement pour sa vie, unissons-nous comme jamais auparavant. ❤️ The DOVEE Project

✨ Faites un don: bit.ly/3pIj2vZ

#MardiJeDonne #OsezRêverFCUSM

Giving Tuesday is nearing its end!⏱ For every woman whose life has been cut short because of ovarian or endometrial cancers. For every mother who won’t see her children grow up because of these diseases. For every woman fighting for her life right now, let’s come together like never before.

✨Donate: bit.ly/38Vtb2o

#GivingTuesday #DreamBigMUHCF
... See MoreSee Less

View on Facebook

Let’s do this, Montreal—we’re more than halfway through Giving Tuesday and we need every one of you to help us reach our $70,000 goal. 🙌 Support Dr. Gilbert, Joanne, Lawrie and the entire The DOVEE Project's Giving Tuesday dream of stopping ovarian and endometrial cancers. Combined, more than 3,000 Canadian women die each year from these cancers—but it doesn’t have to be this way. Let’s stop these deadly killers, once and for all.

✨ Donate now: bit.ly/3nREEEz

Plus de 3 000 Canadiennes succombent chaque année à ces deux cancers, mais nous pouvons les sauver. Arrêtons ces tueurs silencieux, une fois pour toutes.

✨Faites un don: bit.ly/2ISbhCC

#GivingTuesday #DreamBigMUHCF
... See MoreSee Less

View on Facebook

À l’occasion de « Mardi je donne », votre contribution sera égalée jusqu’à concurrence de 50 000 $ grâce à la générosité d’un grand donateur anonyme! La Dre Gilbert et ses collègues Centre universitaire de santé McGill - McGill University Health Centre ont mis au point un test sécuritaire et moins invasif qui permet de dépister les cancers de l’ovaire et de l’endomètre de façon plus précoce que jamais auparavant.

✨ Faites un don: bit.ly/38UHcgN
---
It's Giving Tuesday, and your donation today will be doubled up to $50,000 thanks to a generous anonymous donor. Dr. Gilbert and her colleagues @ The DOVEE Project have developed a test that offers a safe, less invasive way to detect ovarian and endometrial cancers earlier than ever before. The answer for moving this test into clinical implementation? Generous Giving Tuesday supporters like you. ❤️

✨ Donate now: bit.ly/2UEAgvY

#GivingTuesday #DreamBigMUHCF
... See MoreSee Less

View on Facebook

Demain, c’est la journée « Mardi je donne ». Voici un message important de Lawrie Shahbazian, une coordonnatrice du projet DOvEEgene The DOVEE Project

« Les femmes qui reçoivent un diagnostic de cancer de l’ovaire ou de l’endomètre se posent souvent cette question : ‘ J’ai pris soin de ma santé. J’ai passé les examens, les tests Pap et les mammographies. Qu’est-ce que j’aurais pu faire de plus?’ La réponse, c’est DOvEEgene. Notre test minimalement invasif fonctionne, ici et maintenant. Nous en sommes à la dernière étape de notre marathon, le passage aux essais cliniques de stade trois. En tant que jeune femme, je compte bien voir les résultats et les bienfaits de notre travail acharné de mon vivant. Avec votre aide, nous sauverons des vies.”

✨Faites un don: bit.ly/3l1xQ53
... See MoreSee Less

View on Facebook